Pseudoephedrine HCl
NDC 21130-158, Pseudoephedrine HCl, tablet, extended release, from Better Living Brands LLC.
- Product NDC
- 21130-158
- Status
- Listed
- Labeler
- Better Living Brands LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209008
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/21130-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 21130-158-67 | 21130015867 | 2 BLISTER PACK in 1 CARTON (21130-158-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 21130-158 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/21130-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 21130-158. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.